PPI-1019

• CAT Number: I008833
• CAS Number: 290828-45-4
• Molecular Formula: C36H54N6O5
• Molecular Weight: 650.86
• Purity: ≥95%
• Synonyms: PPI-1019; PPI1019; PPI 1019; Apan;(R)-N-((R)-1-(((R)-1-(((R)-1-(((R)-1-amino-4-methyl-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)-4-methyl-2-(methylamino)pentanamide
• Target: beta-amyloid protein inhibitor
• Solubility: Soluble in DMSO
• Storage: 0 - 4 °C for short term, or -20 °C for long term
• IUPAC Name: (2R)-4-methyl-2-[[(2R)-2-[[(2R)-2-[[(2R)-3-methyl-2-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]butanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]pentanamide
• InChI: InChI=1S/C36H54N6O5/c1-22(2)18-27(32(37)43)39-34(45)29(20-25-14-10-8-11-15-25)40-35(46)30(21-26-16-12-9-13-17-26)41-36(47)31(24(5)6)42-33(44)28(38-7)19-23(3)4/h8-17,22-24,27-31,38H,18-21H2,1-7H3,(H2,37,43)(H,39,45)(H,40,46)(H,41,47)(H,42,44)/t27-,28-,29-,30-,31-/m1/s1
• InChIKey: TUSUWHFYKZZRIG-JQWMYKLHSA-N
• SMILES: CC(C)C[C@H](C(=O)N)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](CC(C)C)NC

PPI-1019（Cat No.:I008833）is a small molecule being developed for the treatment of neurological conditions, particularly in stroke and neurodegenerative diseases. It works by targeting and modulating specific ion channels and receptors that are involved in cellular damage and neuroinflammation. PPI-1019 has shown promise in preclinical studies for reducing oxidative stress, preserving neuronal function, and improving cognitive outcomes following ischemic events. The compound is undergoing clinical trials to evaluate its safety, efficacy, and potential to improve neurological recovery, offering a novel approach to treating conditions like stroke and Alzheimer’s disease.